B+
Bull case
25%
Probability
Target price
$123.69
Analysis reference price unavailable
Analysis 2026-01-24 · RankAlpha Sentiment AI
AZN
AstraZenecaFNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive late-stage readouts and a favorable FY2025 beat lead to multiple expansion and re-rating toward the upper analyst range within 12 months.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Late-stage clinical trial failure or delay
Momentum
17
Value
64
Sentiment
18
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $97.65 · Bull $123.69 · Bear $79.98Analysis 2026-01-24; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-24 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $215.39
Why
Momentum17 · Δ7d +3.6
Value64 · Δ7d -0.0
Sentiment18 · Δ7d +2.1
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Late-stage clinical trial failure or delay
- • Macro/currency-driven demand weakness
- • Disappointing guidance, trial setbacks, or regulatory delays compress multiples and push shares toward the lower analyst range.
Catalyst clock
2026-02-10
FY2025 earnings release
Lead driver: Value · See fundamentals
Momentum
17
9% active weight
Current posture
7d trendImproving
Δ7d
+3.6
Δ21d
-0.1
Value
64
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.4
Sentiment
18
62% active weight
Current posture
7d trendImproving
Δ7d
+2.1
Δ21d
+3.9
Why this grade
Composite grade F. Momentum 16.6 / Value 63.8 / Sentiment 18.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-24. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$97.65
Analysis reference price unavailable
Analysis 2026-01-24 · RankAlpha Sentiment AI
B-
Bear case
15%
Probability
Target price
$79.98
Analysis reference price unavailable
Analysis 2026-01-24 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$242.8B
Beta
0.86
Shares Out
1.55B
P/E (TTM)
29.9
P/S (TTM)
4.81
P/FCF (TTM)
60.77
Rev YoY
+6.4%
EPS YoY
+2.3%
Gross Margin
+73.9%
Op Margin
+22.4%
Net Debt
$23.88B
Current Ratio
0.89
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data